Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share (AGMB)

Q: What does CUSIP 00860C102 represent in this 13F holders report?

CUSIP 00860C102 is the security identifier for AGMB - Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share used to aggregate holder disclosures.

Q: How many institutions held AGMB - Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share in Q2 2026?

1 institutional investor reported AGMB - Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 00860C102

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / American Depositary Shares, each representing one common share, no nominal value per share
Total 13F shares: 1,344
Total 13F value: $17,445
Share change: +1,344
SEC-reported price per share: $12.98
Number of holders: 1
Value change: +$17,445
Number of buys: 1
Shares outstanding: 49,208,543

Security key

00860C102

Report period

Q2 2026

Institutions

Top holders

AGMB full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Agomab Therapeutics NV SEC filings Agomab Therapeutics NV company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00860C102

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026

Ownership snapshot

Top reported holders of AGMB - Agomab Therapeutics NV - American Depositary Shares, each representing one common share, no nominal value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

7. Cooperative Ua Lsp

Disclosed value leader

EQT Fund Management S.a r.l.

Comparable rows

15/15

Latest evidence

31 Mar 2026

13D/G 13F 3/4/5 Lead comparable stake: 11% 13D/G row: 7. Cooperative Ua Lsp Showing 1-6 of 15 holder rows.

Quick read

7. Cooperative Ua Lsp leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 7. Cooperative Ua Lsp's linked filing trail.

Comparable ownership Top 5

7. Cooperative Ua Lsp 11%

FMR LLC 10%

Pontifax Management 4 G.P. (2015)... 6.8%

Sanofi 5.7%

Redmile Group, LLC 5.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
7. Cooperative Ua Lsp	13D/G LSP 7 Cooperatieve U.A. 13D/G	11%	— 5,141,992 shares	$0	09 Feb 2026
FMR LLC	13F 13D/G Company 13F 13D/G	10% from 13D/G	$15,301,522 1,458,677 shares	—	31 Mar 2026
Pontifax Management 4 G.P. (2015) Ltd.	13D/G Pontifax VI G.P. L.P. 13D/G	6.8%	— 3,305,846 shares	$0	31 Mar 2026
Sanofi	13F 13D/G Company 13F 13D/G	5.7% from 13D/G	$29,194,677 2,783,096 shares	—	31 Mar 2026
Redmile Group, LLC	13F 13D/G Company 13F 13D/G	5.6% from 13D/G	$1,639,063 156,250 shares	—	31 Mar 2026
Cormorant Asset Management, LP	13F 13D/G Company 13F 13D/G	5% from 13D/G	$25,861,501 2,465,348 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,344

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

-31

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend